Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    Transmissible Spongiform Encephalopathies
Show Display Options
Rank Status Study
1 Completed PRION-1: Quinacrine for Human Prion Disease
Condition: Prion Disease
Intervention: Drug: Quinacrine
2 Recruiting Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers
Condition: Prion Diseases
Intervention: Other: blood draw
3 Recruiting Enhanced CJD Surveillance in the Older Population
Conditions: Prion Disease;   Dementia
Interventions: Other: Medical history questionnaire;   Other: Clinical assessment and review;   Other: Participant follow-up;   Other: Blood sample;   Other: Post mortem examination
4 Not yet recruiting The Role of the Coagulation Pathway at the Synapse in Prion Diseases
Condition: Creutzfeldt-Jakob Syndrome
Intervention: Procedure: collect CSF (Cerebrospinal fluid) sample
5 Completed
Has Results
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
Condition: Creutzfeldt-Jakob Disease
Interventions: Drug: Quinacrine;   Drug: Placebo
6 Active, not recruiting Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.
Condition: Cancer Cachexia
Intervention: Drug: Ruxolitinib
7 Recruiting Genetic Characterization of Movement Disorders and Dementias
Conditions: Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
Intervention:
8 Unknown  Notification of Donors With Positive Microbiology Markers
Conditions: Human Immunodeficiency Virus;   Hepatitis B;   Hepatitis C;   Human T-lymphotropic Virus I & II;   Creutzfeldt-Jakob Syndrome;   HIV Infections
Intervention:

Study has passed its completion date and status has not been verified in more than two years.